Device Surgical Stapling

Gia

Payments companies reported to CMS as associated with Gia. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$14Kassociated payments (2023-2025)

144clinicians with associated payments

1company reporting

By year

2023 $9,838

2024 $3,046

2025 $1,463

Payments reported as associated with Gia, per program year, as reported to CMS.

Who makes it

Medtronic, INC. $14K associated with Gia (2023-2025)

Specialties most often involved

Surgery $8,299

Colon & Rectal Surgery $1,119

Urology $872

Surgical Critical Care $502

General Practice $476

Surgical Oncology $344

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Gia

These are the largest totals companies reported as associated with Gia. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
Francesco Bianco	Chicago, IL	Surgery	$2,288.19
Alvin Goh	New York, NY	Urology	$713.00
Fernando Martinez Colon	Hato Rey, PR	Colon & Rectal Surgery	$569.37
Guillermo Bolanos	Ponce, PR	Surgical Critical Care	$327.10
Karla Ruiz Vega	San Juan, PR	Colon & Rectal Surgery	$288.21
Freddie Velazquez-Feliciano	Humacao, PR	Surgery	$282.53
Jonathan Ramirez Vazquez	Manati, PR	Surgery	$282.53
Miguel Baez Stella	Bayamon, PR	Surgery	$282.53
Luis Bonilla	Manati, PR	Surgery	$282.53
Laura Rodriguez Rivera	Ponce, PR	Surgery	$200.72

Prescribed Gia?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.